Sen. Elizabeth Warren's plan to pay for "Medicare for All" without raising taxes on the middle class departs from how the U.S. has traditionally financed bedrock social insurance programs. That might impact its political viability now and in the future.
Is government-facilitated reimportation of prescription medicines from Canada, a policy now supported by politicians as diverse as President Donald Trump and Senator Bernard Sanders, an issue of free trade or a backdoor method of imposing price controls? That’s the way the question is usually framed in policy debates, but the great Nobel prize-winning economist Milton Friedman took a third view.
It doesn’t take a political science expert to inform the public that our nation is in a period of intense polarization and political strife. It seems that every issue is partisan and that no solution is achievable for an array of topics affecting the American people. However, there seems to be a light at the end of the tunnel. Both Republicans and Democrats are prioritizing a reduction in drug prices. Though there is a persistent debate on what specific policy should be used to reduce drug prices, there are numerous examples of overlap and bipartisan solutions to an issue that has been deemed as complex.
America keeps on getting fatter. Far from helping, Elizabeth Warren’s new plan for Medicare for All could make our obesity crisis worse. Current trends are already quite concerning, according to recently-released CDC data. The new numbers say 40% of American adults are obese, and 18% of children are too — staggering figures, to say the least.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.